SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-20-000049
Filing Date
2020-05-11
Accepted
2020-05-11 16:07:07
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2020-q110xq.htm 10-Q 784438
2 EXHIBIT 31.1 a2020-q110xqex311.htm EX-31.1 13429
3 EXHIBIT 31.2 a2020-q110xqex312.htm EX-31.2 13984
4 EXHIBIT 32.1 a2020-q110xqex321.htm EX-32.1 6621
5 EXHIBIT 32.2 a2020-q110xqex322.htm EX-32.2 6907
12 abushbvpipeline021020.jpg GRAPHIC 56099
  Complete submission text file 0001447028-20-000049.txt   4160726

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abus-20200331.xml EX-101.INS 716229
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20200331.xsd EX-101.SCH 39131
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20200331_cal.xml EX-101.CAL 58512
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20200331_def.xml EX-101.DEF 200525
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20200331_lab.xml EX-101.LAB 472214
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20200331_pre.xml EX-101.PRE 279267
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 20864801
SIC: 2834 Pharmaceutical Preparations